[Malignant neoplasms of vascular origin in children]. 1984

J Anzieta, and P Zolezzi, and L Norambuena, and M Caro, and O Santos, and B Barriga, and I Fernández

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D002081 Buttocks Either of two fleshy protuberances at the lower posterior section of the trunk or HIP in humans and primate on which a person or animal sits, consisting of gluteal MUSCLES and fat. Gluteal Region,Buttock,Gluteal Regions,Region, Gluteal,Regions, Gluteal
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006390 Hemangioendothelioma A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). They affect men and women about equally and rarely develop in childhood. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866) Endothelioma, Vascular,Hemangio-Endothelioma,Endotheliomas, Vascular,Hemangio Endothelioma,Hemangio-Endotheliomas,Hemangioendotheliomas,Vascular Endothelioma,Vascular Endotheliomas
D006393 Hemangiopericytoma A tumor composed of spindle cells with a rich vascular network, which apparently arises from pericytes, cells of smooth muscle origin that lie around small vessels. Benign and malignant hemangiopericytomas exist, and the rarity of these lesions has led to considerable confusion in distinguishing between benign and malignant variants. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1364) Hemangiopericytomas

Related Publications

J Anzieta, and P Zolezzi, and L Norambuena, and M Caro, and O Santos, and B Barriga, and I Fernández
January 1977, Polski przeglad radiologii i medycyny nuklearnej,
J Anzieta, and P Zolezzi, and L Norambuena, and M Caro, and O Santos, and B Barriga, and I Fernández
January 1984, Pneumonologia polska,
J Anzieta, and P Zolezzi, and L Norambuena, and M Caro, and O Santos, and B Barriga, and I Fernández
September 2017, Clinics in laboratory medicine,
J Anzieta, and P Zolezzi, and L Norambuena, and M Caro, and O Santos, and B Barriga, and I Fernández
April 1994, Cancer genetics and cytogenetics,
J Anzieta, and P Zolezzi, and L Norambuena, and M Caro, and O Santos, and B Barriga, and I Fernández
June 1975, Pediatriia,
J Anzieta, and P Zolezzi, and L Norambuena, and M Caro, and O Santos, and B Barriga, and I Fernández
May 1957, The British journal of surgery,
J Anzieta, and P Zolezzi, and L Norambuena, and M Caro, and O Santos, and B Barriga, and I Fernández
June 1978, Science (New York, N.Y.),
J Anzieta, and P Zolezzi, and L Norambuena, and M Caro, and O Santos, and B Barriga, and I Fernández
September 1990, Equine veterinary journal. Supplement,
J Anzieta, and P Zolezzi, and L Norambuena, and M Caro, and O Santos, and B Barriga, and I Fernández
January 1975, Boletin medico del Hospital Infantil de Mexico,
J Anzieta, and P Zolezzi, and L Norambuena, and M Caro, and O Santos, and B Barriga, and I Fernández
January 2003, Vestnik khirurgii imeni I. I. Grekova,
Copied contents to your clipboard!